A major role for neutrophils in experimental bullous pemphigoid.
暂无分享,去创建一个
G. Till | G O Till | J. Troy | G J Giudice | L A Diaz | J A Fairley | Z Liu | X Zhou | S J Swartz | J L Troy | L. Diaz | J. Fairley | G. Giudice | Zhi Liu | Z. Liu | X. Zhou | S. J. Swartz | Xiaoye Zhou | James L. Troy | Gerd O. Till | Luis A Diaz
[1] A. Rot,et al. Chemotactic potency of recombinant human neutrophil attractant/activation protein-1 (interleukin-8) for polymorphonuclear leukocytes of different species. , 1991, Cytokine.
[2] T. Watanabe,et al. Selective Depletion of Rat Neutrophils by In Vivo Administration of a Monoclonal Antibody , 1989, Journal of leukocyte biology.
[3] P. Ward,et al. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. , 1982, The Journal of clinical investigation.
[4] G. Till,et al. The role of complement in experimental bullous pemphigoid. , 1995, The Journal of clinical investigation.
[5] M. Mihm,et al. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. , 1978, The New England journal of medicine.
[6] M. Mihm,et al. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. , 1982, The Journal of investigative dermatology.
[7] Y. Takahashi,et al. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. , 1985, The Journal of investigative dermatology.
[8] J. Schröder,et al. Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin. , 1989, Immunology.
[9] L. Dubertret,et al. Cellular events leading to blister formation in bullous pemphigoid , 1980, The British journal of dermatology.
[10] M. Cybulsky,et al. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. , 1991, Journal of immunology.
[11] T. Hugli,et al. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. , 1994, The American journal of pathology.
[12] M. Raffeld,et al. Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. , 1991, The Journal of investigative dermatology.
[13] J. M. Lipton,et al. Alpha-MSH peptides inhibit acute inflammation induced in mice by rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. , 1992, Cytokine.
[14] J. Schröder,et al. Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light- and electronmicroscopic study. , 1991, The Journal of investigative dermatology.
[15] J. Voorhees,et al. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. , 1982, The New England journal of medicine.
[16] P. Henson,et al. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. , 1978, Journal of immunology.
[17] E. Unanue,et al. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice , 1993, Infection and immunity.
[18] P. Ward,et al. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. , 1993, Journal of immunology.
[19] D M Lewis,et al. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. , 1982, The Journal of investigative dermatology.
[20] A. Ackerman. Histologic Diagnosis of Inflammatory Skin Diseases , 1996 .
[21] B. Dewald,et al. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. , 1989, The American journal of pathology.
[22] D. Priebat,et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. , 1982, The Journal of investigative dermatology.
[23] K. Hashimoto,et al. Eosinophilic spongiosis in bullous pemphigoid. , 1984, Archives of dermatology.
[24] R. Freeman,et al. Herpes gestationis: clinical and histologic features of twenty-eight cases. , 1983, Journal of the American Academy of Dermatology.
[25] J. Troy,et al. Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid. , 1995, Journal of immunology.
[26] D. Lewis,et al. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin. , 1980, The Journal of investigative dermatology.
[27] N. Korman. Bullous Pemphigoid , 1985, Dermatologic clinics.
[28] E. Wilson-Jones,et al. Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus. , 1968, Archives of dermatology.
[29] F. Cunha,et al. IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. , 1991, Immunology.
[30] K. Stenn,et al. Histologic diagnosis of inflammatory skin diseases , 1982 .
[31] J. Troy,et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. , 1993, The Journal of clinical investigation.
[32] M. Cybulsky,et al. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. , 1993, Journal of immunology.
[33] S. Ikeda,et al. Experimental bullous pemphigoid in guinea pigs: the role of pemphigoid antibodies, complement, and migrating cells. , 1984, The Journal of investigative dermatology.
[34] A. Cochran,et al. Mononuclear cell infiltrates in bullous disease. , 1987, The Journal of investigative dermatology.
[35] H. Tagami,et al. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement. , 1983, Acta dermato-venereologica.
[36] A. Haas,et al. cDNA cloning of a novel human ubiquitin carrier protein. An antigenic domain specifically recognized by endemic pemphigus foliaceus autoantibodies is encoded in a secondary reading frame of this human epidermal transcript. , 1992, The Journal of biological chemistry.